THE CRYOGENIC TECHNOLOGIES APPLICATION IN THE COMPLEX TREATMENT OF GALLBLADDER ADENOCARCINOMA WITH INVASION INTO THE PORTAL VEIN BRANCHES: CASE REPORT
DOI:
https://doi.org/10.15407/exp-oncology.2023.03.379Keywords:
gallbladder cancer, cryogenic technologies, portal vein invasionAbstract
The right trisectionectomy is the main treatment modality for locally advanced gallbladder cancer with invasion of the intraparenchymal portal vein branches because it allows the achievement of negative resection margins (R0). However, only 10%—25% of such patients are eligible for surgery. The cryosurgical method has been successfully used in the complex treatment of hepatopancreatobiliary malignant neoplasms for many years. The possibility of its application close to major blood vessels is one of its advantages. In the presented case, the cryodestruction of the residual tumor with invasion into the anterior wall of the left branch of the portal vein was used as a debulking option during liver resection (R2) due to locally advanced gallbladder cancer. The cryodestruction was performed with application method with a double cryocycle and spontaneous thawing using a Cryo-Pulse device and liquid nitrogen as a cryoagent. No postoperative complications related to cryodestruction were noted. The cryogenic technologies application in the debulking surgery of gallbladder cancer can be a safe treatment modality for residual tumors with invasion into the intraparenchymal branches of the portal vein.
References
Song X, Hu Y, Li Y, et al. Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Ther. 2020;5(1):230. https://doi.org/10.1038/s41392-020-00324-2
Krell RW, Alice CW Gallbladder cancer: surgical management. Chin Clin Oncol. 2019;8(4):36. https://doi.org/10.21037/cco.2019.06.06
Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663-673. https://doi.org/10.1016/S1470-2045(18)30915-X
Dronov A, Bakunets P, Dobush R, et al. 15-year experience in the application of cryosurgical technologies in the treatment of patients with neoplasia of the liver and pancreas. Surgery. Eastern Europe. 2019;8(1):57-66.
Kozachuk YeS. Evaluation of the effectiveness of the cryosurgical method in the complex treatment of patients with focal liver pathology (clinical and experimental study) [dissertation]. Kyiv, Ukraine; Bogomolets National Medical University; 2020. 208 p.
McNiel D, Hennemeyer C, Woodhead G, McGregor H. Gallbladder cryoablation: a novel option for high-risk patients with gallbladder disease. Am J Med. 2021;134(3):326-331. https://doi.org/10.1016/j.amjmed.2020.10.007
Sainani NI, Silverman SG, Tuna IS, et al. Incidence and clinical sequelae of portal and hepatic venous thrombosis following percutaneous cryoablation of liver tumors. Abdom Radiol (NY). 2016;41(5):970-977. https://doi.org/10.1007/s00261-015-0626-2
Soule E, Matteo J. Finally, a minimally invasive option for intrahepatic inferior vena cava invasion by hepatocellular carcinoma. Gastrointest Tumors. 2018;5(1-2):54-61. https://doi.org/10.1159/000491694
Esposito P, Matteo M, Concepcion C, et al. Portal vein tumor thrombus: no longer a death sentence. Cureus. 202121;13(1):e12845. https://doi.org/10.7759/cureus.12845
Prochnau D, Figulla HR, Romeike BF, et al. Percutaneous catheter-based cryoablation of the renal artery is effective for sympathetic denervation in a sheep model. Int J Cardiol. 2011;152(2):268-270. https://doi.org/10.1016/j.ijcard.2011.08.001
Forssell C, Bjarnegård N, Nyström FH. A pilot study of perioperative external circumferential cryoablation of human renal arteries for sympathetic denervation. Vasc Specialist Int. 2020;36(3):151-157. https://doi.org/10.5758/vsi.200023
Mauda-Havakuk M, Hawken NM, Owen JW, et al. Comparative analysis of the immune response to RFA and cryoablation in a colon cancer mouse model. Sci Rep. 2022;12(1):18229. https://doi.org/10.1038/s41598-022-22279-w
Yakkala C, Denys A, Kandalaft L, Duran R. Cryoablation and immunotherapy of cancer. Curr Opin Biotechnol. 2020;65:60-64. https://doi.org/10.1016/j.copbio.2020.01.006
Olagunju A, Forsman T, Ward RC. An update on the use of cryoablation and immunotherapy for breast cancer.
Front Immunol. 2022;13:1026475. https://doi.org/10.3389/fimmu.2022.1026475
Abdo J, Cornell DL, Mittal SK, Agrawal DK. Immunotherapy plus cryotherapy: potential augmented abscopal effect for advanced cancers. Front Oncol. 2018;8:85. https://doi.org/10.3389/fonc.2018.00085
Wu Y, Cao F, Zhou D, et al. Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity. Front Immunol. 2022;13:930461. https://doi.org/10.3389/fimmu.2022.930461
Chen Z, Meng L, Zhang J, Zhang X. Progress in the cryoablation and cryoimmunotherapy for tumor. Front Im munol. 2023;14:1094009. https://doi.org/10.3389/fimmu.2023.1094009
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
